All research
2026-06-17 PubMed

MYADM gene family tandem duplication strongly linked to sheep erythrocyte potassium concentration

Sheep erythrocyte potassium locus highlights MYADM family regulation of electroneutral potassium chloride cotransporters (KCC).

Background

The concentration of intracellular potassium in erythrocytes varies significantly among domestic sheep, categorized as low (LK) or high (HK) potassium phenotypes. These differences are linked to varying rates of potassium chloride co-transport (KCC), a crucial mechanism for cellular volume regulation and ion homeostasis. While this trait is inherited as a single locus, the specific genetic variants responsible have remained elusive. Understanding the genetic basis of KCC regulation is vital, as KCCs, particularly KCC3, are implicated in human conditions like hypertension and neurological disorders, highlighting a critical gap in our knowledge of their regulatory mechanisms.

Study Design

Researchers conducted a genome-wide association study (GWAS) in domestic sheep to identify genetic variants associated with erythrocyte intracellular potassium concentration. Following the initial GWAS, fine mapping was performed in an expanded sheep population to pinpoint specific genes within the identified locus. To explore potential molecular interactions, Alphafold3 protein models were utilized to predict how human MYADM protein might interact with KCC3 to influence its activity. The study aimed to link genetic variations in the MYADM family to the observed physiological differences in erythrocyte potassium levels.

Results

The genome-wide association study identified a large, artiodactyl-specific tandem duplication of the MYADM gene family locus as highly associated with erythrocyte intracellular potassium concentration, achieving a remarkable significance of P = 1.1 × 10^-63. This expanded MYADMF locus contained 37 genes in sheep, 33 in goats, 52 in cattle, and 15 in domestic swine, but no comparable expansion in horses. Fine mapping in an expanded sheep population further refined this association, showing maximal linkage to erythrocyte potassium with P < 10^-99 for specific genes: MYADMF15A1, MYADMF1G1, MYADMF1H1, MYADMF3A1, MYADMF1B3, and MYADMF13C1. Prior data indicated higher potassium chloride co-transport in sheep LK erythrocytes compared to HK erythrocytes. The current findings, for the first time, implicate one or more MYADMF genes in the regulation of potassium chloride co-transport. Given fewer MYADM genes in humans, a simpler interaction was hypothesized with the namesake MYADM, which has been linked to human hypertension.

Alphafold3 protein models suggest that human MYADM directly interacts with KCC3 to stabilize its N-terminal regulatory peptide in an inhibitory position. This interaction provides a plausible mechanism for how divergent alleles, such as MYADMF1G1 and MYADMF1B3 (or MYADMF15A1), could cause the low potassium phenotype by affecting KCC3 function.

Key Findings

  • A large, artiodactyl-specific tandem duplication of the MYADM gene family locus is highly associated (P = 1.1 × 10^-63) with erythrocyte potassium concentration.
  • The expanded MYADMF locus includes 37 genes in sheep, 33 in goats, 52 in cattle, and 15 in swine.
  • Fine mapping showed maximal association (P < 10^-99) with MYADMF15A1, MYADMF1G1, MYADMF1H1, MYADMF3A1, MYADMF1B3, and MYADMF13C1.
  • Alphafold3 models suggest human MYADM directly interacts with KCC3 to stabilize its N-terminal regulatory peptide in an inhibitory position.
  • This study is the first to implicate MYADMF genes in the regulation of potassium chloride co-transport.

Why It Matters

This research provides a crucial genetic link to the regulation of potassium chloride co-transporters (KCCs), which are fundamental to cellular ion balance and volume. For researchers and clinicians, identifying the MYADM gene family as a major controller of erythrocyte potassium concentration in sheep opens new avenues for understanding KCC function and dysfunction. The proposed direct interaction between MYADM proteins and KCC3 offers a novel mechanistic insight into how these transporters are regulated, potentially influencing their activity in various physiological and pathological contexts. This discovery could inform future studies on human hypertension, given the established link between human MYADM and blood pressure, and the role of KCC3 in renal and cardiovascular physiology. While direct clinical translation is distant, this work lays foundational groundwork for exploring MYADM-KCC interactions as potential therapeutic targets for ion transport disorders or blood pressure regulation.


myadm kcc potassium erythrocyte genetics gwas
Source: pubmed:42304218 · Ingested 2026-06-17 · Digest: gemini-2.5-flash